期刊
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
卷 65, 期 6, 页码 430-436出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/oem.2007.033977
关键词
-
资金
- NIEHS NIH HHS [ES00002, P30 ES000002] Funding Source: Medline
- NIOSH CDC HHS [R01OH2421, T42OH008416] Funding Source: Medline
- ACL HHS [T42OH008416, R01OH002421] Funding Source: Medline
Because of their high prevalence in the general population, genetic variants that determine susceptibility to environmental exposures may contribute greatly to the development of occupational diseases in the setting of specific exposures occurring in the workplace. Studies investigating genetic susceptibilities in the workplace may: ( 1) provide mechanistic insight into the aetiology of disease, in particular the determination of environmentally responsive genes; ( 2) identify susceptible subpopulations with respect to exposure; and ( 3) provide valuable input in setting occupational exposure limits by taking genetic susceptibility into account. Polymorphisms in the NAT2 and the HLA-DPB1(Glu69) genes provide classic examples of how genetic susceptibility markers have a clear role in identifying disease risk in bladder cancer and chronic beryllium disease, respectively. For diseases with more complex and multifactorial aetiology such as occupational asthma and chronic airways disease, susceptibility studies for selected genetic polymorphisms provide additional insight into the biological mechanisms of disease. Even when polymorphisms for genetic susceptibility have a clear role in identifying disease risk, the value of wide scale genetic screening in occupational settings remains limited due to primarily ethical and social concerns. Thus, large scale genetic screening in the workplace is not currently recommended.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据